je.st
news
Synta CEO Bahcall Resigns as Committee to Run Drugmaker
2014-03-05 01:48:31| Biotech - Topix.net
Synta Pharmaceuticals Corp., the maker of the experimental cancer drug ganetespib, said co- founder Safi Bahcall has resigned as chief executive officer and will be replaced by a committee led by Chairman Keith Gollust until a new top executive is named.
Tags: run
committee
ceo
resigns
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|